FDA Investigator Javier E Santos

Javier E Santos has conducted inspections on 19 sites in 5 countries as of 01 Sep 2010. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
19
Last Inspection Date:
01 Sep 2010
Investigator Role:
FDA Investigator
Redica ID:
100008733
Countries of Inspections:
Spain, United States of America, United Kingdom of Great Britain and Northern Ireland, Ireland, Mexico
FDA Investigators that have inspected at least one site in common with Javier E Santos:
Adetutu M Gidado, Ana P Pineda Zavaleta, Andrew J Barrowcliff, Anita R Michael, Anthony A Charity, Arulvathani P Arudchandran, Azza Talaat, Barbara J Maulfair, Bernice F Hirsch, Bo Chi, PhD, Burnell M Henry, Carl A Huffman, III, CDR Rochelle B Young, RPh, MSA, Charles R Cote, RIC, Christina K Theodorou, Craig D Zagata, Cynthia Jim, CSO, David J Hafner, Demitria J Xiradakis, Denise M Digiulio, Dennis Cantellops Paite, Douglas C Kovacs, Dr. Zhihao Qiu (Peter), PhD, Emest F Bizjak, Eric M Mueller, PharmD, Erika M Wilkerson, Erika V Butler, Erin D Mccaffery, Francis A Guidry, George Pyramides, Guerlain Ulysse, H Ljamilla Selby, Hala L Selby, Heriberto Negron Rivera, Jeffery B Medwid, PhD, Jeffrey A Sommers, Jeffrey Harrison, Jing Fang, José E Meléndez, Joseph L Despins, PhD, Juan Rjimenez Garcia, Junho Pak, Karen E D'orazio, Karthik B Iyer, Karyn M Campbell, Kendra L Brooks, Kevin P Foley, Kristina J Donohue, Kristina Mjoyce Pittman, Kshitij A Patkar, Lakshmi Narasimhan, PhD, Lata C Mathew, PhD, Laura Fontan, MS, LCDR Susan E Polifko, Lisa M Bellows, Lisa M Feola, Lourdes Valentin Aponte, LTJG Bradley E Benasutti, Luella J Rossi, Luis A Dasta, Maria Cecilia Tami, PhD, Maria Gutierrez Hoffman, PhD, Marie F Morin, Mary Davis Lopez, Marybet Lopez Negron, Matthew R Noonan, Melissa T Roy, Michael A Taylor, Michael L Casner, Michael P Sheehan, Michael Shanks, MS, Michele M Falchek, Miguel A Martinez Perez, Milind Ganjawala, Milos Dokmanovic, PhD, Mra Davism, Mra Digiuliod, Mra M Barbosar, Nancy F Scheraga, Niketa Patel, Nikhil Thakur, Rachael O Oyewole, Rafael Nevarez Nieves, Rebecca E Dombrowski, Richard E Needham, Richard Ledwidge (nmi), PhD, Robin P Mathew, Rosa J Motta, Rose Ljean Mary, Sam Pepe, Shelley L Waring, Shirley J Berryman, Stephanie Mangigian, MS/OSH, RN, Stephen J Mottola, Steven A Gonzales, Steven D Kehoe, Susan F Laska, MS, Susan T Hadman, Susanna E Ford, Tammy L Chavis, Tara G Bizjak, Temar Q Williams, Thomas E Friel, Unnee Ranjan, Vlada Matusovsky, Wayne E Seifert, William D Tingley, Xu Michael Di, PhD, Yun Wu, PhD, Yvonne C Mcknight, Yvonne C Wood, Zachary L Stamm

Javier E Santos's Documents

Publish Date Document Type Title
May, 2000 EIR Industrias Farmaceuticas Almirall SA - EIR, 2001-03-26
May, 2000 EIR Ranke Química, SA - EIR, 2000-11-02
September, 2000 EIR Eli Lilly and Company Limited - EIR, 2000-09-22
September, 2000 FDA 483 Response Eli Lilly and Company Limited - Form 483R, 2000-10-05
September, 2010 FDA 483 Eurofins Lancaster Laboratories, Inc - Form 483, 2010-09-07
September, 2002 FDA 483 SGS Chemical Solutions Laboratories Inc. - Form 483, 2002-09-11
May, 2000 FDA 483 Response Industrias Farmaceuticas Almirall SA - Form 483R, 2001-01-29
September, 2000 FDA 483 Eli Lilly Co. Ltd. - Form 483, 2000-09-22
April, 2001 FDA 483 Pharmacia Corporation - Form 483, 2001-04-19
May, 2000 FDA 483 Response Ranke Química, SA - Form 483R, 2000-11-20
September, 2000 FDA 483 Eli Lilly S.A.- Irish Branch - Form 483, 2000-09-27
May, 2000 FDA 483 Sandoz Industrial Products SA - Form 483, 2000-05-17
December, 2003 FDA 483 SGS Chemical Solutions Laboratories Inc. - Form 483, 2003-12-16
June, 2001 FDA 483 ASTB Analytical Services, Inc. - Form 483, 2001-06-27
July, 2003 EIR Integrated Analytical Laboratories, LLC. - EIR, 2003-07-14

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more